ACT

Acetylcysteine for Prevention of Renal Outcomes in Patients Undergoing Coronary and Peripheral Vascular Angiography - Main Results from the Randomized Acetylcysteine for Contrast-Induced Nephropathy Trial – Circulation - 2011

Brief Summary: 

Acetylcysteine does not prevent contrast-induced acute kidney injury in patients undergoing angiography. The study drugs were administered orally twice daily for 2 doses before and 2 doses after the procedure.

Reference:
http://www.ncbi.nlm.nih.gov/pubmed/21859972